Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Net Income (Quarterly): -17.38M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -17.38M |
| September 30, 2023 | -17.40M |
| June 30, 2023 | -22.55M |
| March 31, 2023 | -25.14M |
| December 31, 2022 | -23.92M |
| September 30, 2022 | -29.31M |
| June 30, 2022 | -29.43M |
| March 31, 2022 | -25.10M |
| December 31, 2021 | -20.76M |
| September 30, 2021 | -17.58M |
| June 30, 2021 | -16.12M |
| March 31, 2021 | -16.01M |
| December 31, 2020 | -13.86M |
| September 30, 2020 | -8.085M |
| June 30, 2020 | -8.977M |
| March 31, 2020 | -1.297M |
| December 31, 2019 | -6.409M |
| September 30, 2019 | -5.26M |
| June 30, 2019 | -5.637M |
| March 31, 2019 | -1.339M |
| December 31, 2018 | -4.902M |
| September 30, 2018 | -6.548M |
| June 30, 2018 | -8.871M |
| March 31, 2018 | 2.314M |
| December 31, 2017 | -3.40M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.30M |
| June 30, 2017 | -5.90M |
| March 31, 2017 | -4.40M |
| December 31, 2016 | -9.10M |
| September 30, 2016 | -10.00M |
| June 30, 2016 | -7.00M |
| March 31, 2016 | -5.20M |
| December 31, 2015 | -6.50M |
| September 30, 2015 | -6.60M |
| June 30, 2015 | -19.90M |
| March 31, 2015 | 1.20M |
| December 31, 2014 | 6.50M |
| September 30, 2014 | -6.90M |
| June 30, 2014 | -10.20M |
| March 31, 2014 | 3.20M |
| December 31, 2013 | -0.10M |
| September 30, 2013 | -3.90M |
| June 30, 2013 | -6.702M |
| March 31, 2013 | 0.215M |
| December 31, 2012 | 4.829M |
| September 30, 2012 | -4.09M |
| June 30, 2012 | -2.733M |
| March 31, 2012 | -0.436M |
| December 31, 2011 | -1.99M |
| September 30, 2011 | 0.078M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-29.43M
Minimum
Jun 2022
-1.297M
Maximum
Mar 2020
-16.33M
Average
-17.38M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
| Novavax Inc | -178.39M |
| aTyr Pharma Inc | -14.76M |
| Allogene Therapeutics Inc | -89.26M |
| AIM ImmunoTech Inc | -12.58M |
| Protalix BioTherapeutics Inc | -6.044M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.625M |
| Total Expenses (Quarterly) | 23.52M |
| EPS Diluted (Quarterly) | -0.12 |
| Enterprise Value | 87.01M |
| Profit Margin (Quarterly) | -262.3% |
| Earnings Yield | -79.57% |
| Normalized Earnings Yield | -79.57 |